MEDICIM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICIM
Largest movements
- Financial fixed assets -€6.2m
no longer reported in 2025 (was €6.2m)
- Receivables within one year +€4.1m
up €4.1m (+34.5%), from €11.9m to €16.0m
of which Trade receivables: +€4.3m
- Intangible fixed assets -€832,140
down €832,140 (-6.9%), from €12.0m to €11.2m
- Profit (loss) carried forward -€5.3m
down €5.3m, from €243,939 to -€5.0m
- Short-term financial debts +€2.6m
up €2.6m (+10.2%), from €25.2m to €27.8m
- Trade debts -€323,729
down €323,729 (-36.7%), from €881,265 to €557,535
- Financial charges +€4.8m
up €4.8m (+206%), from €2.3m to €7.1m
of which Non-recurring financial charges: +€5.3m
- Turnover -€923,492
down €923,492 (-4.7%), from €19.6m to €18.6m
- Depreciation -€646,516
down €646,516 (-8.9%), from €7.3m to €6.6m
- Staff costs +€304,617
up €304,617 (+2.2%), from €13.8m to €14.1m
- Other operating income +€274,824
up €274,824 (+20.9%), from €1.3m to €1.6m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €30,631,349 | €27,831,459 | -€2.8m | -9.1% |
| Fixed assets | 21/28 | €18,440,570 | €11,385,844 | -€7.1m | -38.3% |
| Intangible fixed assets | 21 | €11,991,620 | €11,159,479 | -€832,140 | -6.9% |
| Tangible fixed assets | 22/27 | €234,282 | €226,365 | -€7,917 | -3.4% |
| Furniture and vehicles | 24 | €101,342 | €152,815 | +€51,473 | +50.8% |
| Other tangible fixed assets | 26 | €132,940 | €73,550 | -€59,391 | -44.7% |
| Financial fixed assets | 28 | €6,214,668 | - | -€6.2m | |
| Companies linked by participating interests | 282/3 | €6,214,668 | - | -€6.2m | |
| Participating interests | 282 | €6,214,668 | - | -€6.2m | |
| Current assets | 29/58 | €12,190,779 | €16,445,614 | +€4.3m | +34.9% |
| Amounts receivable within one year | 40/41 | €11,899,305 | €16,005,239 | +€4.1m | +34.5% |
| Trade receivables | 40 | €11,685,671 | €15,935,741 | +€4.3m | +36.4% |
| Other amounts receivable | 41 | €213,633 | €69,498 | -€144,135 | -67.5% |
| Cash at bank and in hand | 54/58 | €78 | €78 | = | 0.0% |
| Deferred charges and accrued income | 490/1 | €291,396 | €440,297 | +€148,901 | +51.1% |
| Total equity and liabilities | 10/49 | €30,631,349 | €27,831,459 | -€2.8m | -9.1% |
| Equity | 10/15 | €1,376,477 | -€3,838,320 | -€5.2m | |
| Contributions | 10/11 | €1,029,579 | €1,029,579 | = | 0.0% |
| Capital | 10 | €1,029,579 | €1,029,579 | = | 0.0% |
| Issued capital | 100 | €1,029,579 | €1,029,579 | = | 0.0% |
| Reserves | 13 | €102,958 | €102,958 | = | 0.0% |
| Non-distributable reserves | 130/1 | €102,958 | €102,958 | = | 0.0% |
| Legal reserve | 130 | €102,958 | €102,958 | = | 0.0% |
| Profit (loss) carried forward | 14 | €243,939 | -€5,006,858 | -€5.3m | |
| Investment grants | 15 | - | €36,000 | +€36,000 | |
| Amounts payable | 17/49 | €29,254,872 | €31,669,779 | +€2.4m | +8.3% |
| Amounts payable within one year | 42/48 | €28,762,972 | €31,208,439 | +€2.4m | +8.5% |
| Financial debts | 43 | €25,222,993 | €27,793,193 | +€2.6m | +10.2% |
| Other loans | 439 | €25,222,993 | €27,793,193 | +€2.6m | +10.2% |
| Trade debts | 44 | €881,265 | €557,535 | -€323,729 | -36.7% |
| Suppliers | 440/4 | €881,265 | €557,535 | -€323,729 | -36.7% |
| Taxes, remuneration and social security | 45 | €2,658,715 | €2,857,711 | +€198,996 | +7.5% |
| Taxes | 450/3 | - | €180,018 | +€180,018 | |
| Remuneration and social security | 454/9 | €2,658,715 | €2,677,693 | +€18,978 | +0.7% |
| Accrued charges and deferred income | 492/3 | €491,900 | €461,339 | -€30,561 | -6.2% |
| Operating income | 70/76A | €25,454,976 | €25,902,209 | +€447,233 | +1.8% |
| Turnover | 70 | €19,553,286 | €18,629,794 | -€923,492 | -4.7% |
| Own construction capitalised | 72 | €4,584,527 | €5,680,428 | +€1.1m | +23.9% |
| Other operating income | 74 | €1,317,162 | €1,591,987 | +€274,824 | +20.9% |
| Operating charges | 60/66A | €24,076,329 | €23,884,088 | -€192,240 | -0.8% |
| Services and other goods | 61 | €2,950,109 | €3,040,804 | +€90,695 | +3.1% |
| Remuneration, social security and pensions | 62 | €13,829,288 | €14,133,905 | +€304,617 | +2.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,294,131 | €6,647,615 | -€646,516 | -8.9% |
| Other operating charges | 640/8 | €2,254 | - | -€2,254 | |
| Non-recurring operating charges | 66A | €547 | €61,764 | +€61,218 | +11,197% |
| Operating profit (loss) | 9901 | €1,378,647 | €2,018,120 | +€639,473 | +46.4% |
| Financial income | 75/76B | €310 | €42,554 | +€42,244 | +13,612% |
| Recurring financial income | 75 | €310 | €42,554 | +€42,244 | +13,612% |
| Other financial income | 752/9 | €310 | €42,554 | +€42,244 | +13,612% |
| Financial charges | 65/66B | €2,325,854 | €7,121,472 | +€4.8m | +206% |
| Recurring financial charges | 65 | €1,347,004 | €888,383 | -€458,621 | -34.0% |
| Debt charges | 650 | €1,318,452 | €860,218 | -€458,234 | -34.8% |
| Other financial charges | 652/9 | €28,552 | €28,165 | -€387 | -1.4% |
| Non-recurring financial charges | 66B | €978,850 | €6,233,088 | +€5.3m | +537% |
| Profit (loss) for the period before taxes | 9903 | -€946,897 | -€5,060,797 | -€4.1m | -434% |
| Income taxes | 67/77 | €867 | €190,000 | +€189,133 | +21,818% |
| Taxes | 670/3 | €867 | €190,000 | +€189,133 | +21,818% |
| Profit (loss) for the period | 9904 | -€947,763 | -€5,250,797 | -€4.3m | -454% |
| Profit (loss) for the period to be appropriated | 9905 | -€947,763 | -€5,250,797 | -€4.3m | -454% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.